Cargando…

A comment on participant reimbursement within Australian drug and alcohol research

Detalles Bibliográficos
Autores principales:	Winter, Daniel T., Geiger, Brennan, Day, Carolyn A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540906/ https://www.ncbi.nlm.nih.gov/pubmed/35226383 http://dx.doi.org/10.1111/dar.13452

Ejemplares similares

The "lessons" of the Australian "heroin shortage"
por: Degenhardt, Louisa, et al.
Publicado: (2006)

The Pharmaceutical Pricing and Reimbursement Information (PPRI) network – a decade of exchange of information and policy research?
por: Vogler, Sabine, et al.
Publicado: (2015)

Regarding: “Insurance Reimbursement for Complementary Healthcare Services”
por: Whedon, James M.
Publicado: (2018)

Hospitalizations of nursing homes residents: the role of reimbursement policies
por: Ashton, Toni
Publicado: (2014)

Paying for Outcomes: Innovative Coverage and Reimbursement Schemes for Pharmaceuticals
por: Carlson, Josh, et al.
Publicado: (2009)

The Potential for Early Health Economic Modelling in Health Technology Assessment and Reimbursement Decision-Making Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling"
por: Kim, Hansoo, et al.
Publicado: (2020)

Adequate reimbursement is crucial to support cost-effective rapid on-site cytopathology evaluations
por: Al-Abbadi, Mousa A., et al.
Publicado: (2010)

Helping address the national research and research capacity needs of Australian chiropractic: introducing the Australian Chiropractic Research Network (ACORN) project
por: Adams, Jon, et al.
Publicado: (2015)

The purposes of research support: the Australian example
por: Clarke, Ronald J.
Publicado: (2023)

Bibliometrics, the "Clinical Diagnostics" of Research Impact: Comment on "‘We’re Not Providing the Best Care If We Are Not on the Cutting Edge of Research’: A Research Impact Evaluation at a Regional Australian Hospital and Health Service"
por: Abramo, Giovanni, et al.
Publicado: (2023)

Towards a fair and transparent research participant compensation and reimbursement framework in Vietnam
por: Sansom, Lucy J, et al.
Publicado: (2020)

Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain
por: Schulz, Martin, et al.
Publicado: (2022)

Invited commentary on Australian fetal alcohol spectrum disorder diagnostic guidelines
por: Astley, Susan J
Publicado: (2014)

Cutting Edge Research? Realistic Expectations of Priorities, Scope and Engagement: Comment on "‘We’re Not Providing the Best Care If We Are Not on the Cutting Edge of Research’: A Research Impact Evaluation at a Regional Australian Hospital and Health Service"
por: Williams, Siân, et al.
Publicado: (2023)

Reimbursement Policies for Diabetes Prevention Program (DPP): Implications for Racial and Ethnic Health Disparities
por: Formagini, Taynara, et al.
Publicado: (2021)

How is Clinical Trial Reimbursement Money Spent? South African Trial Participants’ Reported Reimbursement Spending Patterns and Perceptions of Appropriate Reimbursement Amounts
por: Milford, Cecilia, et al.
Publicado: (2021)

Bridging the Gap Between Research and Policy and Practice: Comment on "CIHR Health System Impact Fellows: Reflections on ‘Driving Change’ Within the Health System"
por: McKee, Martin
Publicado: (2019)

Integrating consumer engagement in health and medical research – an Australian framework
por: Miller, Caroline L., et al.
Publicado: (2017)

Commentary: Reimbursement models in pediatric cardiac surgery: The unrefined All Patient Refined Diagnosis-Related Group
por: Karamlou, Tara, et al.
Publicado: (2020)

If Providing Best Care Means Being at the Cutting Edge of Research, Should It Be Implemented System-wide?: Comment on "‘We’re Not Providing the Best Care If We Are Not on the Cutting Edge of Research’: A Research Impact Evaluation at a Regional Australian Hospital and Health Service"
por: Hanney, Stephen R.
Publicado: (2023)

Reshaping Australian drug policy: the dilemmas of generic medicines policy
por: Löfgren, Hans
Publicado: (2007)

Primary Healthcare Policy Research: Including Variables Associated With the Social Determinants of Health Matters Comment on "Universal Health Coverage for Non-communicable Diseases and Health Equity: Lessons From Australian Primary Healthcare"
por: Berg, Shannon
Publicado: (2021)

The Australian mental health system: An economic overview and some research issues
por: Williams, Ruth FG, et al.
Publicado: (2008)

Changing the Discourse in Ambitions Towards Universal Health Coverage: Lessons From Australian Primary Healthcare Comment on "Universal Health Coverage for Non-communicable Diseases and Health Equity: Lessons From Australian Primary Healthcare"
por: Simpson, Sarah J., et al.
Publicado: (2021)

Health research participants are not receiving research results: a collaborative solution is needed
por: Long, Christopher R., et al.
Publicado: (2017)

Study participants incentives, compensation and reimbursement in resource-constrained settings
por: Mduluza, Takafira, et al.
Publicado: (2013)

Conducting decolonizing research and practice with Australian First Nations to close the health gap
por: Laird, Pamela, et al.
Publicado: (2021)

It’s All About the IKT Approach: Three Perspectives on an Embedded Research Fellowship: Comment on "CIHR Health System Impact Fellows: Reflections on ‘Driving Change’ Within the Health System"
por: Cassidy, Christine E., et al.
Publicado: (2019)

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
por: Macabeo, Bérengère, et al.
Publicado: (2023)

Enhancing Multiple Ways of Knowing: Comment on "Evaluating Public Participation in a Deliberative Dialogue: A Single Case Study"
por: Boydell, Katherine M.
Publicado: (2023)

Research participation effects: a skeleton in the methodological cupboard()
por: McCambridge, Jim, et al.
Publicado: (2014)

Retrospective Impact Evaluation Continuing to Prove Challenging Irrespective of Setting: A Study of Research Impact Enablers and Challenges Cloaked as an Impact Evaluation?: Comment on "‘We’re Not Providing the Best Care If We Are Not on the Cutting Edge of Research’: A Research Impact Evaluation at a Regional Australian Hospital and Health Service"
por: Ramanathan, Shanthi
Publicado: (2023)

Reimagining Researchers in Health Research Comment on "Experience of Health Leadership in Partnering With University-Based Researchers in Canada: A Call to ‘Re-Imagine’ Research"
por: Plamondon, Katrina M.
Publicado: (2020)

Re-Framing the Knowledge to Action Challenge Through NIHR Knowledge Mobilisation Research Fellows Comment on "CIHR Health System Impact Fellows: Reflections on ‘Driving Change’ Within the Health System"
por: Rycroft-Malone, Jo, et al.
Publicado: (2020)

Which UHC? Features for Equity and Universalism Comment on "Universal Health Coverage for Non-Communicable Diseases and Health Equity: Lessons From Australian Primary Healthcare"
por: Loewenson, Rene
Publicado: (2021)

Identification and quantification of change in Australian illicit drug markets
por: Gilmour, Stuart, et al.
Publicado: (2006)

Uncovering psychological mechanisms mediating the effects of drugs: some issues and comments using the example of psychedelic drugs
por: Kangaslampi, Samuli
Publicado: (2020)

How to Account for Asymmetries in Deliberative Dialogues: Comment on "Evaluating Public Participation in a Deliberative Dialogue: A Single Case Study"
por: Jiménez-Pernett, Jaime
Publicado: (2023)

Bioelectromagnetics Research within an Australian Context: The Australian Centre for Electromagnetic Bioeffects Research (ACEBR)
por: Loughran, Sarah P., et al.
Publicado: (2016)

Future Research and Policy Directions in Physician Reimbursement
por: McMenamin, Peter
Publicado: (1981)

Cannot write session to /tmp/vufind_sessions/sess_2tf5qlth74qa0i3ugibd6pq9fn